Since 1988, Burns McClellan has provided strategic public and investor relations services to the international life sciences and health community. As a communications consultant, the company advises other companies specializing in pharmaceutical discovery and development, drug delivery, medical devices, and diagnostics, as well as advisory and investment firms specializing in the biotech industry.
The agency's staff, consisting of professionals, have experience in all aspects of communication in the field of natural sciences. The employees have a proven track record in medical research, finance and investment, marketing communications, regulatory affairs, and related disciplines.
Burns McClellan, based in New York, provides access to global markets through a partnership with Hume Brophy, a European communications firm specializing in PR, IR, public relations, corporate and financial communications.